Agent-based model of multicellular tumor spheroid evolution including cell metabolism.


Journal

The European physical journal. E, Soft matter
ISSN: 1292-895X
Titre abrégé: Eur Phys J E Soft Matter
Pays: France
ID NLM: 101126530

Informations de publication

Date de publication:
29 Aug 2019
Historique:
received: 17 10 2018
accepted: 29 07 2019
entrez: 29 8 2019
pubmed: 29 8 2019
medline: 18 1 2020
Statut: epublish

Résumé

Computational models aiming at the spatio-temporal description of cancer evolution are a suitable framework for testing biological hypotheses from experimental data, and generating new ones. Building on our recent work (J. Theor. Biol. 389, 146 (2016)) we develop a 3D agent-based model, capable of tracking hundreds of thousands of interacting cells, over time scales ranging from seconds to years. Cell dynamics is driven by a Monte Carlo solver, incorporating partial differential equations to describe chemical pathways and the activation/repression of "genes", leading to the up- or down-regulation of specific cell markers. Each cell-agent of different kind (stem, cancer, stromal etc.) runs through its cycle, undergoes division, can exit to a dormant, senescent, necrotic state, or apoptosis, according to the inputs from its systemic network. The basic network at this stage describes glucose/oxygen/ATP cycling, and can be readily extended to cancer-cell specific markers. Eventual accumulation of chemical/radiation damage to each cell's DNA is described by a Markov chain of internal states, and by a damage-repair network, whose evolution is linked to the cell systemic network. Aimed at a direct comparison with experiments of tumorsphere growth from stem cells, the present model will allow to quantitatively study the role of transcription factors involved in the reprogramming and variable radio-resistance of simulated cancer-stem cells, evolving in a realistic computer simulation of a growing multicellular tumorsphere.

Identifiants

pubmed: 31456065
doi: 10.1140/epje/i2019-11878-7
pii: 10.1140/epje/i2019-11878-7
doi:

Substances chimiques

Adenosine Triphosphate 8L70Q75FXE
Glucose IY9XDZ35W2
Oxygen S88TT14065

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

112

Références

Oncogene. 2012 May 24;31(21):2614-26
pubmed: 21996747
PLoS Comput Biol. 2013;9(7):e1003120
pubmed: 23874170
Clin Cancer Res. 2010 Jun 15;16(12):3141-52
pubmed: 20530696
Int J Mol Sci. 2017 Sep 13;18(9):null
pubmed: 28902128
Cell Biol Int. 2009 Jan;33(1):65-70
pubmed: 18977451
J Immunol Methods. 2000 Jun 23;240(1-2):79-92
pubmed: 10854603
Int J Radiat Oncol Biol Phys. 1988 May;14(5):947-55
pubmed: 3360660
PLoS Comput Biol. 2010 Feb 26;6(2):e1000684
pubmed: 20195492
Radiat Res. 1987 Oct;112(1):105-15
pubmed: 3659291
Oncotarget. 2016 Jan 12;7(2):1215-26
pubmed: 26527320
J Cell Sci. 2013 Jul 1;126(Pt 13):2761-71
pubmed: 23813965
Eur Biophys J. 2009 Apr;38(4):479-85
pubmed: 19132360
Physiol Rev. 1990 Oct;70(4):1135-76
pubmed: 2217557
Biophys J. 2005 Dec;89(6):3884-94
pubmed: 16199495
Annu Rev Biomed Eng. 2011 Aug 15;13:127-55
pubmed: 21529163
Nat Rev Genet. 2007 Jun;8(6):450-61
pubmed: 17510665
Cancer Res. 1988 May 1;48(9):2432-9
pubmed: 3356007
DNA Cell Biol. 1999 May;18(5):357-67
pubmed: 10360837
J Exp Med. 1973 Oct 1;138(4):745-53
pubmed: 4744009
Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):20863-8
pubmed: 21078958
Strahlenther Onkol. 1991 Dec;167(12):723-5
pubmed: 1662416
J Theor Biol. 2000 Apr 21;203(4):367-82
pubmed: 10736214
Radiat Res. 1989 Apr;118(1):1-20
pubmed: 2704782
Nat Rev Cancer. 2015 Dec;15(12):730-45
pubmed: 26597528
Carcinogenesis. 2010 Jan;31(1):2-8
pubmed: 19861649
Front Oncol. 2013 Mar 15;3:51
pubmed: 23508803
Biomaterials. 2007 Apr;28(11):1998-2009
pubmed: 17239436
Nat Biotechnol. 1997 Aug;15(8):778-83
pubmed: 9255794
Trends Ecol Evol. 2013 Oct;28(10):597-604
pubmed: 23816268
PLoS Comput Biol. 2013;9(11):e1003295
pubmed: 24244120
Cancer Res. 2007 Sep 15;67(18):8671-81
pubmed: 17875707
J Math Biol. 2006 Jul;53(1):86-134
pubmed: 16791651
Nat Rev Mol Cell Biol. 2007 Oct;8(10):839-45
pubmed: 17684528
J Cell Physiol. 1981 Jan;106(1):23-32
pubmed: 7204508
Radiat Res. 1990 Nov;124(2):216-26
pubmed: 2247602
Biol Direct. 2010 Apr 20;5:25
pubmed: 20406443
Radiat Res. 1992 May;130(2):139-47
pubmed: 1574569
Ann Biomed Eng. 2012 Nov;40(11):2488-500
pubmed: 23008097
Br J Cancer. 1986 Mar;53(3):345-53
pubmed: 3964538
Prog Biophys Mol Biol. 1977;32(1):1-82
pubmed: 343173
Cell Syst. 2018 Mar 28;6(3):355-367.e5
pubmed: 29525203
Neoplasia. 2015 Jan;17(1):1-15
pubmed: 25622895
Radiat Res. 2001 Oct;156(4):365-78
pubmed: 11554848
J Theor Biol. 2016 Jan 21;389:146-58
pubmed: 26549470
Semin Cancer Biol. 2015 Feb;30:70-8
pubmed: 24793698
Mitochondrion. 2014 Nov;19 Pt A:78-84
pubmed: 25229666
Cell Prolif. 1992 Jan;25(1):1-22
pubmed: 1540680
J Biotechnol. 2010 Jul 1;148(1):3-15
pubmed: 20097238

Auteurs

Fabrizio Cleri (F)

Institut d'Electronique, Microélectronique et Nanotechnologie (IEMN, UMR Cnrs 8520), 59652, Villeneuve d'Ascq, France. fabrizio.cleri@univ-lille1.fr.
Departement de Physique, Université de Lille, 59650, Villeneuve d'Ascq, France. fabrizio.cleri@univ-lille1.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH